Goodwill and Intangible Assets, Net

6 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The Company evaluates goodwill for impairment on an annual basis in the first fiscal quarter, and more frequently if indicators for potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit. The annual impairment testing performed in fiscal 2025 and fiscal 2024 did not indicate any impairment of goodwill.

Changes in the carrying amount of goodwill were as follows:


(In millions)	U.S. Pharmaceutical		Prescription Technology Solutions		Medical-Surgical Solutions		International		Corporate		Total
Balance, March 31, 2024	$	4,123	$	2,024	$	2,536	$	1,449	$	—	$	10,132
Goodwill acquired	—		—		—		—		—		—
Disposals (1)	—		—		—		(47)		—		(47)

Foreign currency translation adjustments, net	—		—		—		2		—		2
Other adjustments	—		—		(29)		—		29		—
Balance, September 30, 2024	$	4,123	$	2,024	$	2,507	$	1,404	$	29	$	10,087

(1)Goodwill related to the Canadian retail disposal group discussed in Financial Note 2, “Held for Sale.” This amount was included under the caption “Assets held for sale” in the Condensed Consolidated Balance Sheet as of September 30, 2024.

Intangible Assets

Information regarding intangible assets was as follows:


	September 30, 2024								March 31, 2024
(Dollars in millions)	Weighted- Average Remaining Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount			Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Customer relationships	11	$	1,480	$	(604)	$	876		$	1,830	$	(701)	$	1,129
Service agreements	9	1,129		(707)		422			1,126		(676)		450

Trademarks and trade names	13	384		(268)		116			759		(395)		364
Technology	10	284		(133)		151			284		(125)		159
Other	6	34		(26)		8			34		(26)		8
Total		$	3,311	$	(1,738)	$	1,573	(1)	$	4,033	$	(1,923)	$	2,110

(1)Excludes net intangible assets of approximately $419 million related to the Canadian retail disposal group discussed in Financial Note 2, “Held for Sale.” This amount was included under the caption “Assets held for sale” in the Condensed Consolidated Balance Sheet as of September 30, 2024. Amortization of these assets ceased upon classification as held for sale in the second quarter of fiscal 2025.

All intangible assets, except for those classified as held for sale, were subject to amortization as of September 30, 2024 and March 31, 2024. Amortization expense of intangible assets was $60 million and $62 million for the three months ended September 30, 2024 and 2023, respectively, and $123 million and $124 million for the six months ended September 30, 2024 and 2023, respectively. Estimated amortization expense of the assets listed in the table above is as follows: $102 million, $177 million, $171 million, $166 million, and $164 million for the remainder of fiscal 2025 and each of the succeeding years through fiscal 2029, respectively, and $793 million thereafter.